Results 1 - 10 from 10 for "arpim"
-
Christian Rodseth Named President Of Romanian Association of International Drug Manufacturers
03.04.2019
Christian Rodseth, Managing Director at Janssen Romania, is the new president of the Romanian Association of International Drug Manufacturers (ARPIM), which brings together some of the leading players more
-
Popescu, ARPIM: Patients’ Access To Innovative Drugs Still Is 1 To 10 In Romania Vs Western Europe
09.13.2017
-
ARPIM: Original Drug Manufacturers Invested EUR77M In Romania In 2014
06.27.2016
Original medical drugs manufacturers on the Romanian market pumped EUR77.1 million in Romania in 2014, and most of them invested in research and development (R&D) activities in the field of medicine more
-
ARPIM Head: Shortages In Healthcare Caused By Lack Of Financing, Reckless Use Of Existing Funds
09.29.2014
Shortages in Romania’s public healthcare sector are triggered by the lack of financing and the reckless use of existing funds, Calin Galaseanu, president of the Romanian Association of International more
-
Romanian Association of International Drug Manufacturers Names New President
01.13.2014
The Romanian Association of International Drug Manufacturers (ARPIM) named Calin Galaseanu, head of pharmaceutical company Bristol-Myers Squibb Romania, as president of the association, replacing more
-
ARPIM: Clawback Tax Payment To Cover Costs With Extending Compensated Medicine List
05.29.2013
Costs entailed by the introduction of new medicines on the list of compensated drugs will be entirely covered by drug producers through the clawback tax they are obliged to pay, the Romanian more
-
ARPIM Names Johnson&Johnson Romania’s Head As President
01.09.2013
Romanian Association of International Drug Producers ARPIM named the head of pharmaceutical company Johnson&Johnson Romania, Efthymios (Makis) Papataxiarchis, as president in December, instead of more
-
ARPIM: Romania Ranks Last In EU By Costs With Medical Care, Drugs
11.26.2012
Romania ranks last in the European Union in terms of costs with medical care and drugs, which triggers a life expectancy shorter by five years than the European average and over EUR18 billion in more
-
Drug Makers Blast Romania's “Unsustainable” Clawback Tax
10.04.2011
Romania’s pharmaceutical industry could lose 842 million lei (EUR195 million), which means a 30% shrinking of the market, following the implementation of the new clawback tax, according to a survey more
-
ARPIM: Romania Ranks Last In EU By Investments In Drug Research And Development
05.25.2011
Romania ranks last in the European Union by investments in the research and development of new drugs, with an average EUR5 per capita, the local association of international drug makers ARPIM said more